Pharmaplaz, Samaritan deal

The companies extended to Oct. 16 the due date for Pharmaplaz to pay LIV $8.6 million under a March 2007 deal to develop and manufacture LIV's SP-01A (see BioCentury, April 2). The due date had been S...